Are you attending the @MDAorg Clinical & Scientific Conference? Check out the two #OPMD sessions highlighting data and updates from our clinical program and presented by Benitec CEO Jerel Banks, M.D., Ph.D. We hope to see you there!.#MDAConference #MuscularDystrophy

We’re honored to participate in this year’s.@MDAorg Gene Therapy Summit & engage with leading physicians & researchers in #musculardystrophy as we continue to drive important progress in innovations for #neuromuscular diseases. More:

We are dedicated to the advancement of our unique AAV-based gene therapy, BB-301, to transform the treatment landscape for Oculopharyngeal Muscular Dystrophy (OPMD). Learn more:.#meded

Removal from Official List $BLT -

Implementation of Scheme of Arrangement $BLT -

Benitec Inc Appoints Edward Smith to the Board of Directors $BLT -

Voluntary delisting of ADSs and Warrants from Nasdaq $BLT -

Position on FIRB approval $BLT -

Suspension from Official Quotation $BLT -

Trading Halt $BLT -

Pause in Trading $BLT -

Court approves re-domiciliation scheme $BLT -

Change of Director's Interest Notice $BLT -

Results of Scheme Meeting $BLT -

Chairperson's address and presentation for Scheme Meeting $BLT -

COVID-19 information relating to Scheme Meeting $BLT -

Appendix 4D and Half Year Report $BLT -

Scheme Booklet $BLT -

Court orders convening of Scheme Meeting $BLT -

Appendix 4C - quarterly $BLT -